Hypothesis-based weight-of-evidence evaluation of the human carcinogenicity of toluene diisocyanate

Critical Reviews in Toxicology

Volumn 43, Issue 5, 2013, Pages 391-435

  Prueitt, Robyn L ^a   Rhomberg, Lorenz R ^a   Goodman, Julie E ^a  

^a GRADIENT   (United States)

Author keywords

Carcinogenicity; Epidemiology; Genotoxicity; Inhalation bioassay; Isocyanates; Risk assessment; Toxicokinetics; Weight of evidence

Indexed keywords

CARCINOGEN; TOLUENE DIISOCYANATE;

ANGIOSARCOMA; BIOASSAY; BREAST TUMOR; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CARCINOGENICITY; CAUSAL ATTRIBUTION; DISEASE ASSOCIATION; DNA ADDUCT; EPIDEMIOLOGICAL DATA; FIBROMA; FIBROSARCOMA; GENOTOXICITY; HEMANGIOMA; HODGKIN DISEASE; HUMAN; HYPOTHESIS; HYPOTHESIS BASED WEIGHT OF EVIDENCE; INHALATION; KIDNEY CANCER; LARYNX CANCER; LEUKEMIA; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER TUMOR; LUNG ADENOMA; LUNG CANCER; LYMPHOMA; NONHUMAN; PANCREAS CANCER; PANCREAS ISLET CELL TUMOR; RECTUM CANCER; REVIEW; RISK ASSESSMENT; SWEDEN; UNITED KINGDOM; UNITED STATES;

ADMINISTRATION, ORAL; ANIMALS; CARCINOGENS; HUMANS; INHALATION EXPOSURE; MICE; NEOPLASMS; OCCUPATIONAL EXPOSURE; PHENYLENEDIAMINES; RATS; SPECIES SPECIFICITY; TOLUENE 2,4-DIISOCYANATE;

EID: 84878243604     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.3109/10408444.2013.790877     Document Type: Review

References (106)

1. Allport DC, Gilbert DS, Pemberton D, Tury B. (2003). Excerpt re: physical and fire properties of MDI and TDI. In: Allport DC, Gilbert DS, Outterside SM, eds. MDI & TDI: safety, health, and the environment. A source book and practical guide. New York: John Wiley and Sons, Inc., p310-19.
2. American Conference of Governmental Industrial Hygienists (ACGIH). (2012). 2012 Guide to occupational exposure values. American Conference of Governmental Industrial Hygienists (ACGIH) (Cincinnati, OH), ACGIH Publication No. 0390. 240p.
3. Andersen M, Binderup ML, Kiel P, et al. (1980). Mutagenic action of isocyanates used in the production of polyurethanes. Scand J Work Environ Health, 6, 221-6.
4. Anderson D, Styles JA. (1978). The bacterial mutation test. Six tests for carcinogenicity. Br J Cancer, 37, 924-30.
5. Baillie TA, Slatter JG. (1991). Glutathione: a vehicle for the transport of chemically reactive metabolites in vivo. Acc Chem Res, 24, 264-70.
6. Benford DJ, Riley RA. (1988). TDI-mutagenicity study for the detection of unscheduled DNA synthesis ex vivo in hepatocytes and lung following a single exposure of tdi to rats by inhalation. International Isocyanate Institute (III) Report 10547.
7. Benford DJ, Riley RA. (1989). Mutagenicity study for the detection of unscheduled DNA synthesis ex vivo in hepatocytes and lung following exposure of toluene diisocyanate to rats by inhalation for five successive days. Unpublished study report by Bayer AG, Germany.
8. Bilban M. (2004). Mutagenic testing of workers exposed to toluene-diisocyanates during plastics production process. Am J Ind Med, 45, 468-74.
9. 0-methylenediphenyl diisocyanate: epidemiological and experimental evidence. Crit Rev Toxicol, 31, 737-72.
10. Boorman GA, Eustis SL. (1984). Proliferative lesions of the exocrine pancreas in male F344/N rats. Environ Heath Perspect, 56, 213-17.
11. Brorson T, Skarping G, Renman L, Sango C. (1989). Test atmospheres of diisocyanates with special reference to controlled exposure of humans. Int Arch Occup Environ Health, 61, 495-501.
12. Brorson T, Skarping G, Sango C. (1991). Biological monitoring of isocyanates and related amines. IV. 2, 4-and 2, 6-toluenediamine in hydrolysed plasma and urine after test-chamber exposure of humans to 2, 4-and 2, 6-toluene diisocyanate. Int J Occup Environ Health, 63, 253-9.
13. Brown WE, Aul DJ, Stock MF, et al. (1993). Comparative uptake and distribution of 14C labeled diisocyanates. Pharmacol Toxicol, 73, 63.
14. Cohen SM, Storer RD, Criswell KA, et al. (2009). Hemangiosarcoma in rodents: mode-of-action evaluation and human relevance. Toxicol Sci, 111, 4-18.
15. Collins MA. (2002). Toxicology of toluene diisocyanate. Appl Occup Environ Hyg, 17, 846-55.
16. Commission of the European Communities (CEC). (1998). Commission Directive 98/98/EC of 15 December 1998 adapting to technical progress for the 25 time Council Directive 67/548/EEC on the approximation of laws, regulations, and administrative provisions relating to the classification, packaging and labeling of dangerous substances. Off J Eur Comm, 41, 386-9.
17. Curran-Everett D. (2000). Multiple comparisons: philosophies and illustrations. Am J Physiol Regul Integr Comp Physiol, 279, R1-8.
18. Czuppon AB, Marczynski B, Baur X. (1992). Detection of protein changes in serum of workers following inhalation exposure to toluene diisocyanate vapors. Toxicol Ind Health, 8, 407-13.
19. Day BW, Jin R, Basalyga DM, et al. (1997). Formation, solvolysis, and transcarbamoylation reactions of bis(S-glutathionyl) adducts of 2, 4-and 2, 6-diisocyanatotoluene. Chem Res Toxicol, 10, 424-31.
20. Day BW, Jin R, Karol MH. (1996). In vivo and in vitro reactions of toluene diisocyanate isomers with guinea pig hemoglobin. Chem Res Toxicol, 9, 568-73.
21. Dieter MP, Boorman GA, Jameson CW, et al. (1990). The carcinogenic activity of commercial grade toluene diisocyanate in rats and mice in relation to the metabolism of the 2, 4-and 2, 6-TDI isomers. Toxicol Ind Health, 6, 599-21.
22. European Commission. 2008. European union risk assessment report. 4-Methyl-M-phenylenediamine (toluene-2, 4-diamine) risk assess ment. CAS-No.: 95-80-7. EINECS-No.: 202-453-1. Final approved version. Available from: http://esis.jrc.ec.europa.eu/doc/existing-chemicals/risk-assessment/REPORT/ 24tdareport064.pdf [last accessed 1 Mar 2013].
23. Gahlmann R, Herbold B, Ruckes A, Seel K. (1993). Tests on the stability of aromatic diisocyanates in dimethylsulphoxide (DMSO): toluene diisocyanate (TDI) and diphenylmethane diisocyanate (MDI) in the Ames test. [Untersuchungen zur stabilitat aromatischer diisocyanate in dimethylsulfoxid (DMSO): toluylendiisocyanat (TDI) und diphenyl-methandiisocyanat (MDI) im Ames-test]. Zentralbl Arbeitsmed Arbeitsschutz Prophyl Ergonomie, 43, 34-8.
24. Gulati DK, Witt K, Anderson B, et al. (1989). Chromosome aberration and sister chromatid exchange tests in Chinese hamster ovary cells in vitro. III. Results with 27 chemicals. Environ Molec Mutagen, 13, 133-93.
25. Hagmar L, Stromberg U, Welinder H, Mikoczy Z. (1993b). Incidence of cancer and exposure to toluene diisocyanate and methylene diphenyldiisocyanate: a cohort based case-referent study in the polyurethane foam manufacturing industry. Br J Ind Med, 50, 1003-7.
26. Hagmar L, Welinder H, Mikoczy Z. (1993a). Cancer incidence and mortality in the Swedish polyurethane foam manufacturing industry. Br J Ind Med, 50, 537-43.
27. Hahn FF, Gigliotti A, Hutt JA. (2007). Comparative oncology of lung tumors. Toxicol Pathol, 35, 130-5.
28. Haseman JK. (1983). A reexamination of false-positive rates for carcinogenesis studies. Fund Appl Toxicol, 3, 334-9.
29. Herbold B, Haas P, Seel K, Walber U. (1998). Studies on the effect of the solvents dimethylsulfoxide and ethyleneglycoldimethylether on the mutagenicity of four types of diisocyanates in the Salmonella/microsome test. Mutat Res, 412, 167-75.
30. Hoffman HD, Leibold E, Ehnes C, et al. (2010). Dermal uptake and excretion of 14C-toluene diisocyante (TDI) and 14C-methylene diphenyl diisocyanate (MDI) in male rats. Clinical signs and histopathology following dermal exposure of male rats to TDI. Toxicol Lett, 199, 364-71.
31. Holdren MW, Spicer CW, Riggin RM. (1984). Gas phase reaction of toluene diisocyanate with water vapor. Am Ind Hyg Assoc J, 45, 626-33.
32. Holmen A, Akesson B, Hansen L, et al. (1988). Comparison among five mutagenicity assays in workers producing polyurethane foams. Int Arch Occup Environ Health, 60, 175-9.
33. International Agency for Research on Cancer (IARC). (1999). IARC monographs on the evaluation of carcinogenic risks to humans: volume 71. Re-evaluation of some organic chemicals, hydrogen, and hydrogen peroxide (in 3 parts). World Health Organization (WHO) IARC Monograph No. 71, 1586p.
34. Japan Chemical Industry Ecology-Toxicology and Information Center (JETOC). (1996). Mutagenicity Test data of existing chemical substances based on the toxicity investigation system of the industrial safety and health law. Chemical Substance Investigation Division, Industrial Safety and Health Department, Labour Standards Bureau, Ministry of Labour, Japan.
35. Japanese Ministry of Health, Labour, and Welfare (JMHLW). (2001). Toxicity testing reports of environmental chemicals. Office of Chemical Safety, Evaluation and Licensing Division, Pharmaceutical and Medical Safety Bureau. Volume 8(2).
36. Jeong YC, Kim DH, Kim BR, Park M. (1998a). In vitro and in vivo reactions of 2, 4-toluene diisocyanate with DNA and blood proteins. J Toxicol Sci, 23, 660-1.
37. Jeong YC, Park M, Kim DH. (1998b). Covalent interactions of toluenediisocyanate with DNA and proteins. J Toxicol Pub Health, 14, 525-33.
38. Jin R, Day BW, Karol MH. (1993). Toluene diisocyanate protein adducts in the bronchoalveolar lavage of guinea pigs exposed to vapors of the chemical. Chem Res Toxicol, 6, 906-12.
39. Jurek AM, Greenland S, Maldonado G. (2008). How far from nondifferential does exposure or disease misclassification have to be to bias measures of association away from the null? Int J Epidemiol, 37, 382-5.
40. Jurek AM, Greenland S, Maldonado G, Church TR. (2005). Proper interpretation of non-differential misclassification effects: expectations vs. observations. Int J Epidemiol, 34, 680-7.
41. Karol MH, Jin R, Lantz RC. (1997). Immunohistochemical detection of toluene diisocyanate (TDI) adducts in pulmonary tissue of guinea pigs following inhalation exposure. Inhal Toxicol, 9, 63-83.
42. Kennedy AL, Stock MF, Alarie Y, Brown WE. (1989). Uptake and distribution of 14C during and following inhalation exposure to radioactive toluene diisocyanate. Toxicol Appl Pharmacol, 100, 280-92.
43. Kennedy AL, Wilson TR, Stock MF, et al. (1994). Distribution and reactivity of inhaled 14C-labeled toluene diisocyanate (TDI) in rats. Arch Toxicol, 68, 434-43.
44. Lange RW, Day BW, Lemus R, et al. (1999a). Intracellular S-glutathionyl adducts in murine lung and human bronchoepithelial cells after exposure to diisocyanatotoluene. Chem Res Toxicol, 12, 931-6.
45. Lange RW, Lantz RC, Stole DB, et al. (1999b). Toluene diisocyanate colocalizes with tubulin on cilia of differentiated human airway epithelial cells. Toxicol Sci, 50, 64-71.
46. Lantz RC, Lange RW, Lemus R, Karol MH. (2001). Rapid reduction of intracellular glutathione in human bronchial epithelial cells exposed to occupational levels of toluene diisocyanate. Toxicol Sci, 60, 348-55.
47. Lind P, Dalene M, Lindstrom V, et al. (1997a). Albumin adducts in plasma from workers exposed to toluene diisocyanate. Analyst, 122, 151-4.
48. Lind P, Dalene M, Skarping G, Hagmar L. (1996). Toxicokinetics of 2, 4-and 2, 6-toluenediamine in hydrolysed urine and plasma after occupational exposure to 2, 4-and 2, 6-toluene diisocyanate. Occup Environ Med, 53, 94-9.
49. Lind P, Dalene M, Tinnerberg H, Skarping G. (1997b). Biomarkers in hydrolysed urine, plasma and erythrocytes among workers exposed to thermal degradation products from toluene diisocyanate foam. Analyst, 122, 51-6.
50. 0-methylenediphenyl diisocyanate (MDI). Mutat Res, 723, 1-10.
51. Loeser E. (1983). Long-term toxicity and carcinogenicity studies with 2, 4/2, 6-toluene-diisocyanate (80/20) in rats and mice. Toxicol Lett, 15, 71-81.
52. Mackay JM. (1992). Toluene di-isocyanate: an evaluation in the mouse micronucleus test. ICI Central Toxicology Laboratory, Report No. CTL/P/2626, Cheshire, United Kingdom.
53. Maitre A, Berode M, Perdrix A, et al. (1993). Biological monitoring of occupational exposure to toluene diisocyanate. Int Arch Occup Environ Health, 65, 97-100.
54. Maki-Paakkanen J, Norppa H. (1987). Chromosome aberrations and sister-chromatid exchanges induced by technical grade toluene diisocyanate and methylenediphenyl diisocyanate in cultured human lymphocytes. Toxicol Lett, 36, 37-43.
55. Marczynski B, Czuppon AB, Marek W, Baur X. (1992). Indication of DNA strand breaks in human white blood cells after in vitro exposure to toluene diisocyanate (TDI). Toxicol Ind Health, 8, 157-69.
56. Marczynski B, Czuppon AB, Schreiber GH, et al. (1993). DNA doublestrand breaks and apoptosis after in vitro exposure to toluene diisocyanate. Toxicol In Vitro, 7, 531-5.
57. Marczynski B, Merget R, Mensing T, et al. (2005). DNA strand breaks in the lymphocytes of workers exposed to diisocyanates: indications of individual differences in susceptibility after low-dose and short-term exposure. Arch Toxicol, 79, 355-62.
58. Marczynski B, Merget R, Teschner B, et al. (2003). Changes in low molecular weight DNA fragmentation in white blood cells after diisocyanate exposure of workers. Arch Toxicol, 77, 470-6.
59. McGregor DB, Brown AG, Howgate S, et al. (1991). Responses of the L5178Y mouse Lymphoma cell forward mutation assay. V: 27 coded chemicals. Environ Mol Mutagen, 17, 196-219.
60. Mikoczy Z, Welinder H, Tinnerberg H, Hagmar L. (2004). Cancer incidence and mortality of isocyanate exposed workers from the Swedish polyurethane foam industry: updated findings 1959-98. Occup Environ Med, 61, 432-7.
61. Mormann W, Frank P, Schupp T, Seel K. (2008). Reactions of N-acetylcysteine adducts of aromatic (di)isocyanates with functional groups of organic molecules: transcarbamoylation reactions in aqueous buffer and in an organic solvent. EXCLI J, 7, 19-43.
62. Mraz J, Bouskova S. (1999). 2, 4-Toluenediisocyanate and hexamethy-lene-diisocyanate adducts with blood proteins: assessment of reactivity of amino acid residues in vitro. Chem Biol Interact, 117, 173-86.
63. Muller K. (2008). TDI inhalation study: tumor statistics review. International Isocyanate Institute (III) Report 11544.
64. National Toxicology Program (NTP). (1979). Bioassay of 2, 4-diamino-toluene for possible carcinogenicity (CAS No. 95-80-7). National Cancer Institute Technical Report Series No. 162. Available from: http://ntp.niehs.nih.gov/ntp/htdocs/LT-rpts/tr162.pdf [last accessed 1 Mar 2013].
65. 1 mice (gavage studies). National Toxicology Program Technical Report Series No. 251. Available from: http://ntp.niehs.nih.gov/ntp/htdocs/LT-rpts/tr251.pdf [last accessed 1 Mar 2013].
66. National Toxicology Program (NTP). (1989a). Rodent bone marrow cytogenetics-chromosome aberrations. Study ID: 544551. Available from: http://ntp-apps.niehs.nih.gov/ntp-tox/index.cfm?fuseaction= invivoca. casummary&study-no=544551&cas-no=26471%2D62%2D 5&endpointlist=CA [last accessed 1 Mar 2013].
67. National Toxicology Program (NTP). (1989b). Rodent bone marrow cytogenetics-sister chromatid exchange. Study ID: 544551. Available from: http://ntp-apps.niehs.nih.gov/ntp-tox/index.cfm?fus eaction=invivosc. scsummary&study-no=544551&cas-no =26471% 2D62%2D5&endpointlist=SC [last accessed 1 Mar 2013].
68. National Toxicology Program (NTP). (1994). NTP comparative toxicology studies of corn oil, safflower oil, and tricaprylin (CAS Nos. 8001-30-7, 8001-23-8, and 538-23-8) in male F344/N rats as vehicles for gavage. National Toxicology Program Technical Report Series No. 426. Available from: http://ntp.niehs.nih.gov/ntp/htdocs/LT-rpts/tr426.pdf [last accessed 1 Mar 2013].
69. National Toxicology Program (NTP). (2011). Report on carcinogens. 12th edition. Available from: http://ntp.niehs.nih.gov/go/roc12, 499p [last accessed 1 Mar 2013].
70. Nikitin AY, Alcaraz A, Anver MR, et al. (2004). Classification of proliferative pulmonary lesions of the mouse: recommendations of the Mouse Models of Human Cancers Consortium. Cancer Res, 64, 2307-16.
71. Owen PE. (1984). The toxicity and carcinogenicity to rats of toluene diisocyanate vapour administered by inhalation for a period of 113 weeks. Addendum Report Volume 1. III Report 10233.
72. Peel M, Marczynski B, Baur X. (1997). Comparison of the binding potential of various diisocyanates on DNA in vitro. J Toxicol Environ Health, 52, 517-26.
73. Prueitt RL, Goodman JE, Bailey LA, Rhomberg LR. (2011). Hypothesis-based weight-of-evidence evaluation of the neurodevelopmental effects of chlorpyrifos. Crit Rev Toxicol, 41, 822-903.
74. Purchase IF, Longstaff E, Ashby J, et al. (1978). An evaluation of 6 short-term tests for detecting organic chemical carcinogens. Br J Cancer, 37, 873-903.
75. Reisser M, Schmidt BF, Brown WE. (2002). Synthesis, characterization, and solvolysis of mono-and bis-S-(glutathionyl) adducts of methy-lene-bis- (phenylisocyanate) (MDI). Chem Res Toxicol, 15, 1235-41.
76. Rhomberg LR, Bailey LA, Goodman JE. (2010). Hypothesis-based weight of evidence: a tool for evaluating and communicating uncertainties and inconsistencies in the large body of evidence in proposing a carcinogenic mode of action-naphthalene as an example. Crit Rev Toxicol, 40, 671-96.
77. Rhomberg LR, Bailey LA, Goodman JE, et al. (2011). Is exposure to formaldehyde in air causally associated with leukemia?-a hypothesis-based weight-of-evidence analysis. Crit Rev Toxicol, 41, 555-621.
78. Risser R, Horowitz JM, McCubrey J. (1983). Endogenous mouse leukemia viruses. Annu Rev Genet, 17, 85-121.
79. Rosenberg C, Savolainen H. (1985). Detection of urinary amine metabolites in toluene diisocyanate exposed rats. J Chromatogr, 323, 429-33.
80. Rosenberg C, Savolainen H. (1986). Determination of occupational exposure to toluene diisocyanate by biological monitoring. J Chromatogr, 367, 385-92.
81. Sabbioni G, Gu Q, Vanimireddy LR. (2012). Determination of isocyan-ate specific albumin-adducts in workers exposed to toluene diisocya-nates. Biomarkers, 17, 150-9.
82. Sabbioni G, Hartley R, Schneider S. (2001). Synthesis of adducts with amino acids as potential dosimeters for the biomonitoring of humans exposed to toluenediisocyanate. Chem Res Toxicol, 14, 1573-83.
83. Sabbioni G, Lamb JH, Farmer PB, Sepai O. (1997). Reactions of 4-methylphenyl isocyanate with amino acids. Biomarkers, 2, 223-32.
84. Sakkinen K, Tornaeus J, Hesso A, et al. (2011). Protein adducts as biomarkers of exposure to aromatic diisocyanates in workers manufacturing polyurethane (PUR) foam. J Environ Monit, 13, 957-65.
85. Saunders J, Frisch K. (1962). Polyurethanes chemistry and toxicology. New York: Interscience Publishers.
86. Schnorr TM, Steenland K, Egeland GM, et al. (1996). Mortality of workers exposed to toluene diisocyanate in the polyurethane foam industry. Occup Environ Med, 53, 703-7.
87. Seel K, Walber U, Herbold B, Kopp R. (1999). Chemical behaviour of seven aromatic diisocyanates (toluenediisocyanates and diphenyl-methanediisocyanates) under in vitro conditions in relationship to their results in the Salmonella/microsome test. Mutat Res, 438, 109-23.
88. 0-methylenediphenyl diisocyanate. Biomarkers, 8, 204-17.
89. 0-methyle-nediphenyl diisocyanate exposure of rats. Chem Biol Interact, 97, 185-98.
90. Shaddock JG, Robinson BY, Casciano DA. (1990). Effect of pretreatment with hepatic mixed-function oxidase inducers on the genotoxicity of four rat carcinogens in the hepatocyte/DNA repair assay. Mutagenesis, 5, 387-91.
91. Sielken RL, Bretzlaff RS, Valdez-Flores C, Parod R. (2012). Statistical comparison of carcinogenic effects and dose-response relationships in rats and mice for 2, 4-toluene diamine to those ascribed to toluene diisocyanate. J Human Ecol Risk Assessment, 18, 1315-37.
92. Skarping G, Brorson T, Sango C. (1991). Biological monitoring of isocyanates and related amines. III. Test chamber exposure of humans to toluene diisocyanate. Int Arch Occup Environ Health, 63, 83-8.
93. Skarping G, Dalene M, Lind P. (1994). Determination of toluenediamine isomers by capillary gas chromatography and chemical ionization mass spectrometry with special reference to the biological monitoring of 2, 4-and 2, 6-toluene diisocyanate. J Chromatogr A, 663, 199-210.
94. Sorahan T, Nichols L. (2002). Mortality and cancer morbidity of production workers in the UK flexible polyurethane foam industry: updated findings, 1958-98. Occup Environ Med, 59, 751-8.
95. Sorahan T, Pope D. (1993). Mortality and cancer morbidity of production workers in the United Kingdom flexible polyurethane foam industry. Br J Ind Med, 50, 528-36.
96. Timchalk C, Smith FA, Bartels MJ. (1994). Route-dependent comparative metabolism of [14C]toluene 2, 4-diisocyanate and [14C]toluene 2, 4-diamine in Fischer 344 rats. Toxicol Appl Pharmacol, 124, 181-90.
97. Tinnerberg H, Dalene M, Skarping G. (1997). Air and biological monitoring of toluene diisocyanate in a flexible foam plant. Am Ind Hyg Assoc J, 58, 229-35.
98. US Food and Drug Administration (FDA). (2001). Guidance for industry: statistical aspects of the design, analysis, and interpretation of chronic rodent carcinogenicity studies of pharmaceuticals (Draft). Center for Drug Evaluation and Research (CDER). Available from: http://www.fda.gov/downloads/ Drugs/Guidance ComplianceRegulatoryInformation/Guidances/ucm079272.pdf [last accessed 1 Mar 2013]
99. Wacholder S, Hartge P, Lubin JH, Dosemeci M. (1995). Non-differential misclassification and bias towards the null: a clarification [Letter to the editor]. Occup Environ Med, 52, 557.
100. Whong WZ, Stewart JD, Ong T. (1991). Study on the formation of DNA adducts and cytogenetic effects in the lung of rats treated with toluene diisocyanate and toluenediamine. Environ Mol Mutagen 17(Suppl. 19):76. In 22nd Annual Scientific Meeting of the Environmental Mutagen Society, April 6-11, Kissimmee, Florida, Abstract No. 272.
101. Wisnewski AV, Hettick JM, Siegel PD. (2011). Toluene diisocyanate reactivity with glutathione across a vapor/liquid interface and subsequent transcarbamoylation of human albumin. Chem Res Toxicol, 24, 1686-93.
102. Witschi H, Espiritu I, Dance ST, Miller MS. (2002). A mouse lung tumor model of tobacco smoke carcinogenesis. Toxicol Sci, 68, 322-30.
103. World Health Organization (WHO). (1987). Environmental health criteria 75, toluene diisocyanates. International Programme on Chemical Safety, p1-72.
104. Yakabe Y, Henderson KM, Thompson WC, et al. (1999). Fate of methylenediphenyl diisocyanate and toluene diisocyanate in the aquatic environment. Environ Sci Technol, 33, 2579-83.
105. Yeh HJ, Lin WC, Shih TS, et al. (2008). Urinary excretion of toluene diisocyanates in rats following dermal exposure. J Appl Toxicol, 28, 189-95.
106. Zeiger E, Anderson B, Haworth S, et al. (1987). Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals. Environ Mutagen, 9, 1-109.